Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus

Behavioural Brain Research

Volumn 244, Issue , 2013, Pages 70-81

  Zhang, Jia ^a   Zhena, Yan Feng ^a   Pu Bu Ci Ren, ^b,d   Song, Li Gang ^a,c   Kong, Wei Na ^c   Shao, Tie Mei ^c   Li, Xue ^c   Chai, Xi Qing ^a,c,d  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Department of Special Consultation   (China)

^c HEBEI CHEMICAL AND PHARMACEUTICAL COLLEGE   (China)

^d Laboratory of Hebei Province   (China)

Author keywords

Alzheimer's disease; Cognitive deficit; NADPH oxidase; Nuclear factor B; Oxidative stress; Salidroside

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN[1-40]; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; GLUTATHIONE PEROXIDASE; HUPERZINE A; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SALIDROSIDE;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG RESPONSE; DRUG TARGETING; EXPERIMENTAL RAT; HIPPOCAMPUS; IN VIVO STUDY; INFLAMMATION; LEARNING; MALE; MAZE TEST; MEMORY CONSOLIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TASK PERFORMANCE;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMYLOID BETA-PEPTIDES; ANIMALS; COGNITION DISORDERS; CYCLOOXYGENASE 2; GLUCOSIDES; HIPPOCAMPUS; INFLAMMATION MEDIATORS; MALE; MAZE LEARNING; MICROINJECTIONS; NADPH OXIDASE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHENOLS; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC;

EID: 84874390596     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.01.037     Document Type: Article

References (77)

1. Alagiakrishnan K., Gill S.S., Fagarasanu A. Genetics and epigenetics of Alzheimer's disease. Postgraduate Medical Journal 2012, 88:522-529.
2. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
3. Maccioni R.B., Farias G., Morales I., Navarrete L. The revitalized tau hypothesis on Alzheimer's disease. Archives of Medical Research 2010, 41:226-231.
4. Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. Journal of Neurology, Neurosurgery & Psychiatry 1999, 66:137-147.
5. Rasgon N., Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. Journals of Gerontology Series A: Biological and Medical Sciences 2004, 59:178-183. discussion 84-92.
6. Finch C.E., Cohen D.M. Aging, metabolism, and Alzheimer disease: review and hypotheses. Experimental Neurology 1997, 143:82-102.
7. Csernansky J.G., Bardgett M.E., Sheline Y.I., Morris J.C., Olney J.W. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology 1996, 46:1715-1720.
8. Squitti R., Polimanti R. Copper hypothesis in the missing hereditability of sporadic Alzheimer's disease: ATP7B gene as potential harbor of rare variants. Journal of Alzheimer's Disease 2012, 29:493-501.
9. Milton R.H., Abeti R., Averaimo S., DeBiasi S., Vitellaro L., Jiang L., et al. CLIC1 function is required for beta-amyloid-induced generation of reactive oxygen species by microglia. Journal of Neuroscience 2008, 28:11488-11499.
10. Choi S.H., Aid S., Kim H.W., Jackson S.H., Bosetti F. Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. Journal of Neurochemistry 2012, 120:292-301.
11. Aiken C.T., Kaake R.M., Wang X., Huang L. Oxidative stress-mediated regulation of proteasome complexes. Molecular & Cellular Proteomics 2011, 10. R110.006924.
12. Kang J., Park E.J., Jou I., Kim J.H., Joe E.H. Reactive oxygen species mediate A beta(25-35)-induced activation of BV-2 microglia. Neuroreport 2001, 12:1449-1452.
13. Martin-Moreno A.M., Reigada D., Ramirez B.G., Mechoulam R., Innamorato N., Cuadrado A., et al. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Molecular Pharmacology 2011, 79:964-973.
14. Origlia N., Righi M., Capsoni S., Cattaneo A., Fang F., Stern D.M., et al. Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction. Journal of Neuroscience 2008, 28:3521-3530.
15. Fang F., Lue L.F., Yan S., Xu H., Luddy J.S., Chen D., et al. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB Journal 2010, 24:1043-1055.
16. Carrano A., Hoozemans J.J., van der Vies S.M., Rozemuller A.J., van Horssen J., de Vries H.E. Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxidants & Redox Signaling 2011, 15:1167-1178.
17. Cao L.L., Du G.H., Wang M.W. Effect of salidroside on mitochondria injury induced by sodium azide. Yao Xue Xue Bao 2005, 40:700-704.
18. Zuo G., Li Z., Chen L., Xu X. Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease. Antiviral Research 2007, 76:86-92.
19. Zhang J., Liu A., Hou R., Jia X., Jiang W., Chen J. Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway. European Journal of Pharmacology 2009, 607:6-14.
20. Ye S.S., Zeng Y.Y., Yin L.L. Effects of salidroside on proliferation, apoptosis, phagocytosis, ROS and NO production of murine peritoneal macrophages in vitro. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2011, 27:237-241.
21. Zhu Y., Shi Y.P., Wu D., Ji Y.J., Wang X., Chen H.L., et al. Salidroside protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via PI3K-Akt dependent pathway. DNA and Cell Biology 2011, 30:809-819.
22. Zhong H., Xin H., Wu L.X., Zhu Y.Z. Salidroside attenuates apoptosis in ischemic cardiomyocytes: a mechanism through a mitochondria-dependent pathway. Journal of Pharmacological Sciences 2010, 114:399-408.
23. Guan S., Xiong Y., Song B., Song Y., Wang D., Chu X., et al. Protective effects of salidroside from Rhodiola rosea on LPS-induced acute lung injury in mice. Immunopharmacology and Immunotoxicology 2012, 34:667-672.
24. Li F., Tang H., Xiao F., Gong J., Peng Y., Meng X. Protective effect of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice. Molecules 2011, 16:9912-9924.
25. 2-induced apoptosis in PC12 cells by preventing cytochrome c release and inactivating of caspase cascade. Acta Biochimica et Biophysica Sinica (Shanghai) 2008, 40:796-802.
26. Jang S.I., Pae H.O., Choi B.M., Oh G.S., Jeong S., Lee H.J., et al. Salidroside from Rhodiola sachalinensis protects neuronal PC12 cells against cytotoxicity induced by amyloid-beta. Immunopharmacology and Immunotoxicology 2003, 25:295-304.
27. Zhang L., Yu H., Zhao X., Lin X., Tan C., Cao G., et al. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochemistry International 2010, 57:547-555.
28. 2-induced cell apoptosis in primary culture of rat hippocampal neurons. Molecular and Cellular Biochemistry 2009, 332:85-93.
29. Zou Y.Q., Cai Z.Y., Mao Y.F., Li J.B., Deng X.M. Effects of salidroside-pretreatment on neuroethology of rats after global cerebral ischemia-reperfusion. Zhong Xi Yi Jie He Xue Bao 2009, 7:130-134.
30. 2-induced neurotoxicity in vitro. Neurotoxicity Research 2012, 21:358-367.
31. Wu J., Bie B., Yang H., Xu J.J., Brown D.L., Naguib M. Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency. Neurobiology of Aging 2013, 34:791-804.
32. Xuan A., Long D., Li J., Ji W., Zhang M., Hong L., et al. Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer's disease. Journal of Neuroinflammation 2012, 9:202.
33. Han M., Liu Y., Tan Q., Zhang B., Wang W., Liu J., et al. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease. European Journal of Pharmacology 2011, 657:104-110.
34. Cancino G.I., Toledo E.M., Leal N.R., Hernandez D.E., Yevenes L.F., Inestrosa N.C., et al. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. Brain 2008, 131:2425-2442.
35. Shi Z., Sun X., Liu X., Chen S., Chang Q., Chen L., et al. Evaluation of an Abeta(1-40)-induced cognitive deficit in rat using a reward-directed instrumental learning task. Behavioural Brain Research 2012, 234:323-333.
36. Pi R., Mao X., Chao X., Cheng Z., Liu M., Duan X., et al. Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-β-mediated Alzheimer's disease-associated pathogenesis in vitro and in vivo. PLoS One 2012, 7:e31921.
37. Tsukuda K., Mogi M., Iwanami J., Min L.J., Sakata A., Jing F., et al. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension 2009, 54:782-787.
38. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 1984, 11:47-60.
39. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chemical Research in Toxicology 1992, 5:227-231.
40. Shi Q., Yan H., Li M.Y., Harding J.J. Effect of a combination of carnosine and aspirin eye drops on streptozotocin-induced diabetic cataract in rats. Molecular Vision 2009, 15:2129-2138.
41. Reale M., de Angelis F., di Nicola M., Capello E., di Ioia M., Luca G., et al. Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients. International Journal of Molecular Sciences 2012, 13:12656-12664.
42. Austin S.A., Santhanam A.V., Katusic Z.S. Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circulation Research 2010, 107:1498-1502.
43. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends in Pharmacological Sciences 1991, 12:383-388.
44. Kozikowski A.P., Miller C.P., Yamada F., Pang Y.P., Miller J.H., McKinney M., et al. Delineating the pharmacophoric elements of huperzine A: importance of the unsaturated three-carbon bridge to its AChE inhibitory activity. Journal of Medicinal Chemistry 1991, 34:3399-3402.
45. Eslinger P.J., Damasio A.R. Preserved motor learning in Alzheimer's disease: implications for anatomy and behavior. Journal of Neuroscience 1986, 6:3006-3009.
46. Markesbery W.R. The role of oxidative stress in Alzheimer disease. Archives of Neurology 1999, 56:1449-1452.
47. Nelson V.M., Dancik C.M., Pan W., Jiang Z.G., Lebowitz M.S., Ghanbari H.A. PAN-811 inhibits oxidative stress-induced cell death of human Alzheimer's disease-derived and age-matched olfactory neuroepithelial cells via suppression of intracellular reactive oxygen species. Journal of Alzheimer's Disease 2009, 17:611-619.
48. Aitken R.J., Jones K.T., Robertson S.A. Reactive oxygen species and sperm function - in sickness and in health. Journal of Andrology 2012, 33:1096-1106.
49. Papanicolaou K.N., Ngoh G.A., Dabkowski E.R., O'Connell K.A., Ribeiro R.F., Stanley W.C., et al. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. American Journal of Physiology - Heart and Circulatory Physiology 2012, 302:H167-H179.
50. Omar R.A., Chyan Y.J., Andorn A.C., Poeggeler B., Robakis N.K., Pappolla M.A. Increased expression but reduced activity of antioxidant enzymes in Alzheimer's disease. Journal of Alzheimer's Disease 1999, 1:139-145.
51. Choi J., Rees H.D., Weintraub S.T., Levey A.I., Chin L.S., Li L. Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. The Journal of Biological Chemistry 2005, 280:11648-11655.
52. Ferrer I. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease. Neuropathology and Applied Neurobiology 2002, 28:441-451.
53. Shi Q., Fu J., Ge D., He Y., Ran J., Liu Z., et al. Huperzine A ameliorates cognitive deficits and oxidative stress in the hippocampus of rats exposed to acute hypobaric hypoxia. Neurochemical Research 2012, 37:2042-2052.
54. Melo J.B., Agostinho P., Oliveira C.R. Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neuroscience Research 2003, 45:117-127.
55. Abramov A.Y., Jacobson J., Wientjes F., Hothersall J., Canevari L., Duchen M.R. Expression and modulation of an NADPH oxidase in mammalian astrocytes. Journal of Neuroscience 2005, 25:9176-9184.
56. Pang T., Wang J., Benicky J., Sanchez-Lemus E., Saavedra J.M. Telmisartan directly ameliorates the neuronal inflammatory response to IL-1beta partly through the JNK/c-Jun and NADPH oxidase pathways. Journal of Neuroinflammation 2012, 9:102.
57. Abramov A.Y., Duchen M.R. The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides. Philosophical Transactions of the Royal Society of London B: Biological Sciences 2005, 360:2309-2314.
58. Syed I., Kyathanahalli C.N., Kowluru A. Phagocyte-like NADPH oxidase generates ROS in INS 832/13 cells and rat islets: role of protein prenylation. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2011, 300:R756-R762.
59. Holmes C., Cunningham C., Zotova E., Woolford J., Dean C., Kerr S., et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009, 73:768-774.
60. Zandi E., Karin M. Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex. Molecular and Cellular Biology 1999, 19:4547-4551.
61. Zhu H., Li Y.R. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Experimental Biology and Medicine (Maywood) 2012, 237:474-480.
62. Sethi G., Sung B., Aggarwal B.B. Nuclear factor-kappaB activation: from bench to bedside. Experimental Biology and Medicine (Maywood) 2008, 233:21-31.
63. Min K.J., Pyo H.K., Yang M.S., Ji K.A., Jou I., Joe E.H. Gangliosides activate microglia via protein kinase C and NADPH oxidase. Glia 2004, 48:197-206.
64. Lee S.Y., Lee J.W., Lee H., Yoo H.S., Yun Y.P., Oh K.W., et al. Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Research. Molecular Brain Research 2005, 140:45-54.
65. Guan S., Feng H., Song B., Guo W., Xiong Y., Huang G., et al. Salidroside attenuates LPS-induced pro-inflammatory cytokine responses and improves survival in murine endotoxemia. International Immunopharmacology 2011, 11:2194-2199.
66. Lee Y.J., Choi D.Y., Choi I.S., Han J.Y., Jeong H.S., Han S.B., et al. Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-beta generation and inflammatory reactions via inhibition of NF-kappaB and STAT3 activation in cultured astrocytes and microglial BV-2 cells. Journal of Neuroinflammation 2011, 8:132.
67. Zong H., Madden A., Ward M., Mooney M.H., Elliott C.T., Stitt A.W. Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. Journal of Biological Chemistry 2010, 285:23137-23146.
68. Takuma K., Fang F., Zhang W., Yan S., Fukuzaki E., Du H., et al. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:20021-20026.
69. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nature Medicine 2003, 9:907-913.
70. Deane R., Singh I., Sagare A.P., Bell R.D., Ross N.T., LaRue B., et al. A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. The Journal of Clinical Investigation 2012, 122:1377-1392.
71. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
72. Lue L.F., Walker D.G., Brachova L., Beach T.G., Rogers J., Schmidt A.M., et al. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Experimental Neurology 2001, 171:29-45.
73. Mukherjee T.K., Mukhopadhyay S., Hoidal J.R. The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochimica et Biophysica Acta 2005, 1744:213-223.
74. Yeh C.H., Sturgis L., Haidacher J., Zhang X.N., Sherwood S.J., Bjercke R.J., et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes 2001, 50:1495-1504.
75. Schmidt A.M., Stern D.M. Hyperinsulinemia and vascular dysfunction: the role of nuclear factor-kappaB, yet again. Circulation Research 2000, 87:722-724.
76. Bierhaus A., Illmer T., Kasper M., Luther T., Quehenberger P., Tritschler H., et al. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 1997, 96:2262-2271.
77. Galluzzi K.E., Appelt D.M., Balin B.J. Modern care for patients with Alzheimer disease: rationale for early intervention. The Journal of the American Osteopathic Association 2010, 110:S37-S42.